Previous studies have shown that breast cancer survivors who meet the current exercise recommendations (2.5 hours of moderate intensity physical activity per week) are at 25% lower risk for dying from breast cancer. New research from the U.S.
Researchers from University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine have published new findings in the February issue of American Journal of Roentgenology that mammography remains beneficial for women in their 40s.
An early stage study shows melatonin - a hormone that regulates the body's sleep and awake cycles - may have the potential to help slow the growth of certain breast cancer tumors, according to researchers from Henry Ford Hospital in Detroit and Foundation for Research Support of the State of São Paulo.
A new study, published in the American Association for Cancer Research's journal Cancer Prevention Research, challenges the current recommendations for management of a type of breast tissue abnormality.
A new US study finds that yoga can benefit breast cancer survivors by reducing fatigue and inflammation. While yoga has many components, the researchers believe breathing and meditation probably had the biggest impact.
Breast cancer tumors have long been classified according to their expression of three surface proteins: estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2).These classifications are used to determine best treatments and prognoses, but are not adequate to describe tumor characteristics or compare them to normal breast tissue.
Survivors of breast cancer have a one in six chance of developing breast cancer in the other breast. But a study conducted in mice suggests that survivors can dramatically reduce that risk through treatment with moderate doses of radiation to the unaffected breast at the same time that they receive radiation therapy to their affected breast.
About three-quarters of breast cancers, the most common cancer in women in the U.S., are estrogen hormone dependent. Patients with this type of breast cancer are initially treated with drugs that block estrogen, such as Tamoxifen. However, one-third to half of these patients eventually become resistant to this treatment.
Researchers in Australia have found that breast stem cells and their "daughters" have a longer life than previously believed. This newly discovered longer lifespan suggests that these cells could carry damage or genetic defects earlier in life that eventually lead to cancer decades later.
Researchers at Cardiff University are developing a novel compound known to reverse the spread of malignant breast cancer cells.The vast majority of deaths from cancer result from its progressive spread to vital organs, known as metastasis. In breast cancer up to 12,000 patients a year develop this form of the disease, often several years after initial diagnosis of a breast lump.
